North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2017-2023)

  • ID: 4481676
  • Report
  • Region: America, North America, United States
  • 72 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Alcon Inc. (Novartis)
  • Allergan Plc
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • InnFocus Inc.
  • iSTAR Medical
  • MORE
The North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is expected to witness market growth of 28.6% CAGR during the forecast period (2017 - 2023).
Minimally invasive glaucoma surgery (MIGS) devices are used to treat glaucoma to provide a safer and lesser invasive means of reducing intraocular pressure (IOP), as compared to conventional glaucoma surgery devices. MIGS devices is expected to be most preferred surgical modality during the forecast period to treat glaucoma. It limits the dependency on conventional medications as well as cuts the complications associated with traditional procedures. MIGS devices are used in combined cataract surgeries through phacoemulsification.
Growing cases of glaucoma on a global level, reoccurrence of glaucoma along with other disorders of the eyes, and growing demand for ab interno approach to treat glaucoma are the factors that contribute to the market growth. Glaucoma is mostly prevalent in the geriatric population, who suffer from mild to moderate glaucoma conditions, primary angle-closure glaucoma, and secondary angle-closure glaucoma. This is expected to be a factor that is expected to drive the growth of this market. Ineffective drug delivery has propelled the transition of glaucoma treatment, from medication to minimally invasive glaucoma surgery (MIGS) devices, and as a result, adding to the market growth. Additionally, growing investment in the emerging economies and initiatives taken to reduce the burden of glaucoma on a global level is expected to provide excellent market opportunities during the forecast period.

Based on Surgery, the market report segments the market into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma. The market by target segment covers Trabecular Meshwork, Suprachoroidal Space, and Other Targets. Based on product, the market is segment into MIGS Stents, MIGS Shunts, and Other Products. The end User covered under the report is Eye Hospitals, Ophthalmology Clinics, and Outpatient Surgical Centers. The report also covers country wise segmentation of Minimally Invasive Glaucoma Surgery (MIGS) Devices market. The countries included in the report are US, Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market. Key companies profiled in the report include Ellex Medical Lasers Ltd, Allergan Plc, Santen Pharmaceutical Co., Ltd., Glaukos Corporation, Alcon Inc. (Novartis), Lumenis, Ivantis, Inc., iSTAR Medical, InnFocus Inc., and SOLX, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alcon Inc. (Novartis)
  • Allergan Plc
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • InnFocus Inc.
  • iSTAR Medical
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery
1.4.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Target
1.4.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
1.4.4 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End User
1.4.5 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
1.5 Methodology for the research

2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

3. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
3.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
3.1.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Stand-Alone Glaucoma Market by Country
3.1.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Glaucoma in Conjunction with Cataract Market by Country

4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
4.1 Introduction
4.1.1 North America Eye Hospitals Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
4.1.2 North America Ophthalmology Clinics Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
4.1.3 North America Outpatient Surgical Centers Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country

5. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
5.1 Introduction
5.1.1 North America Suprachoroidal Space Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
5.1.2 North America Trabecular Meshwork Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
5.1.3 North America Other Targets Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country

6. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
6.1 Introduction
6.1.1 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices in MIGS Shunts Market by Country
6.1.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices in MIGS Stents Market by Country
6.1.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices in Other Products Market by Country

7. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
7.1 US Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.1.1 US Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.1.2 US Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.1.3 US Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.1.4 US Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.2.1 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.2.2 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.2.3 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.2.4 Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.3.1 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.3.2 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.3.3 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.3.4 Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
7.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
7.4.1 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
7.4.2 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
7.4.3 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
7.4.4 Rest of North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product

8. Company Profile
8.1 Ellex Medical Lasers Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expense
8.2 Allergan Plc
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.3 Santen Pharmaceutical Co., Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development Expense
8.5 Alcon Inc. (Novartis)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Research & Development Expense
8.6 Lumenis
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Ivantis, Inc.
8.7.1 Company Overview
8.8 iSTAR Medical
8.8.1 Company Overview
8.9 InnFocus Inc.
8.9.1 Company Overview
8.1 SOLX, Inc
8.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ellex Medical Lasers Ltd.
  • Allergan Plc
  • Santen Pharmaceutical Co., Ltd.
  • Glaukos Corporation
  • Alcon Inc. (Novartis)
  • Lumenis
  • Ivantis, Inc.
  • iSTAR Medical
  • SOLX, Inc
  • InnFocus Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll